ANI Pharmaceuticals Inc’s recent filing unveils that its SVP & CFO CAREY STEPHEN P. unloaded Company’s shares for reported $0.42 million on Dec 17 ’24. In the deal valued at $55.79 per share,7,500 shares were sold. As a result of this transaction, CAREY STEPHEN P. now holds 154,468 shares worth roughly $8.24 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, CAREY STEPHEN P. bought 7,500 shares, generating $414,375 in total proceeds.
Before that, Cook Meredith sold 250 shares. ANI Pharmaceuticals Inc shares valued at $14,060 were divested by the SR. VP, GENERAL COUNSEL & SEC. at a price of $56.24 per share. As a result of the transaction, Cook Meredith now holds 55,988 shares, worth roughly $2.99 million.
Leerink Partners initiated its ANI Pharmaceuticals Inc [ANIP] rating to an Outperform in a research note published on December 11, 2024; the price target was $80. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. CapitalOne began covering ANIP with “an Overweight” recommendation on March 15, 2024. H.C. Wainwright maintained its rating on August 22, 2023. It rated ANIP as “a Buy”.
Price Performance Review of ANIP
On Friday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock fall -1.68% to $53.35. Over the last five days, the stock has lost -5.73%. ANI Pharmaceuticals Inc shares have fallen nearly -3.25% since the year began. Nevertheless, the stocks have risen 1.95% over the past one year. While a 52-week high of $70.81 was reached on 03/25/24, a 52-week low of $52.00 was recorded on 12/19/24. SMA at 50 days reached $57.81, while 200 days put it at $61.80.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 52.71, which if violated will result in even more drops to 52.08. On the upside, there is a resistance level at 54.27. A further resistance level may holdings at 55.20. The Relative Strength Index (RSI) on the 14-day chart is 36.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.59, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.89%. Stochastics %K at 11.06% indicates the stock is a buying.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2024-11-29, dropping by -0.32 million shares to a total of 1.84 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 2.16 million shares. There was a decline of -17.17%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 01, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $55 price target.
